Company Filing History:
1 out of 832,843 Years Active: 2004
Title: The Innovative Contributions of Erika Bergsten
Introduction
Erika Bergsten is a notable inventor based in Stockholm, Sweden. She has made significant contributions to the field of angiogenesis through her innovative research and patent work. Her dedication to advancing medical science is evident in her groundbreaking inventions.
Latest Patents
Erika holds a patent for "In vivo stimulation of angiogenic activity." This patent describes a method for stimulating angiogenesis by introducing two replication-deficient adenovirus vectors to endothelial cells or nearby cells in an organism. The first vector encodes VEGF-B or a fragment thereof, while the second vector encodes VEGF-A or VEGF-C, or fragments thereof. This innovative approach has the potential to enhance therapeutic strategies in various medical applications.
Career Highlights
Throughout her career, Erika has demonstrated a strong commitment to research and innovation. Her work has not only contributed to her field but has also paved the way for future advancements in medical treatments. With her patent, she has established herself as a key figure in the study of angiogenesis.
Collaborations
Erika has collaborated with esteemed colleagues, including Berndt Enholm and Didier Branellec. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Erika Bergsten's contributions to the field of angiogenesis through her patent and collaborative efforts highlight her role as an influential inventor. Her innovative approach to stimulating angiogenic activity showcases the potential for advancements in medical science.